BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11928793)

  • 1. Essential parameters in breast cancer: histopathology reporting guidelines.
    Quinn CM; Lioe T
    Ir Med J; 2002 Jan; 95(1):8-11. PubMed ID: 11928793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standards of pathohistologic processing of breast cancer. A contribution to quality assurance in pathology and patient care].
    Bässler R; Schnürch HG
    Gynakologe; 1994 Feb; 27(1):23-36. PubMed ID: 8168734
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More on breast cancer guidelines.
    Rieckenberg M
    CMAJ; 1998 Jun; 158(11):1426-7; author reply 1429-30. PubMed ID: 9629098
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast (Br J Surg 2008; 95: 547-554).
    Meijnen P; Rutgers EJ
    Br J Surg; 2008 Oct; 95(10):1305; author reply 1305. PubMed ID: 18763257
    [No Abstract]   [Full Text] [Related]  

  • 7. More on breast cancer guidelines.
    Ramsay WR
    CMAJ; 1998 Jun; 158(11):1427, 1429; author reply 1429-30. PubMed ID: 9629099
    [No Abstract]   [Full Text] [Related]  

  • 8. Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal.
    McMasters KM; Chao C; Wong SL; Martin RC; Edwards MJ
    Cancer; 2002 Jul; 95(1):15-20. PubMed ID: 12115311
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guidelines for pathology--supplement to European guidelines for quality assurance in mammography screening. Report by the Pathology Working Group of the European Community].
    Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Böcker W; Bussolati G; Connolly CE; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Holland R; Jacquemier J; Lacerda M; Lindgren A; Martinez-Peñuela J; Peterse JL; Rank F; Tsakraklides V; de Wolf C; Zafrani B
    Pathologe; 1997 Jan; 18(1):71-88. PubMed ID: 9157408
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast.
    Ansari B; Ogston SA; Purdie CA; Adamson DJ; Brown DC; Thompson AM
    Br J Surg; 2008 May; 95(5):547-54. PubMed ID: 18386775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update: breast cancer guidelines.
    Edge S; Theriault R
    J Natl Compr Canc Netw; 2003 Oct; 1 Suppl 3():S-3-8. PubMed ID: 23570131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
    Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 14. [Expression of vascular endothelial growth factor A and C in human breast cancer and their significance].
    Hu SE; Zhang YJ; Cui YM; Zhang HQ
    Ai Zheng; 2005 Sep; 24(9):1076-9. PubMed ID: 16159428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
    Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
    Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer.
    Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W
    J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast.
    Cheung KJ; Tam W; Chuang E; Osborne MP
    Breast J; 2007; 13(4):413-7. PubMed ID: 17593048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast-conserving surgery in breast cancer].
    Ruggiero R; Procaccini E; Freda F; Iovino F; Irlandese E; Gili S; Lo Schiavo F
    G Chir; 2005; 26(11-12):449-52. PubMed ID: 16472427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant tuberculosis and metastasis in axillary lymph nodes: a diagnostic surprise.
    Gaurav M; Rajgopal S; Mary M; Bhavatej E
    ANZ J Surg; 2008 Sep; 78(9):825-6. PubMed ID: 18844925
    [No Abstract]   [Full Text] [Related]  

  • 20. Extramedullary haematopoiesis in axillary lymph nodes following neoadjuvant chemotherapy for locally advanced breast cancer--a potential diagnostic pitfall.
    Millar EK; Inder S; Lynch J
    Histopathology; 2009 Apr; 54(5):622-3. PubMed ID: 19413641
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.